Everything new is good, so here is a rundown of what I’ve found to be good, bad and ugly on the three new devices: the Dexcom G4, t:slim insulin pump, and Bayer Contour NEXT fingerstick meter.

For those new to the wacky world of diabetes, back in 2006 Bayer acquired privately held Metrika, the makers of the A1CNow. Back in the day the A1CNow was the only at home A1C test on the market and the acquisition was generally viewed as a positive step for Bayer.

The good news: The Diabetes Technology Society pitched a plan that, if established, would create a post-market quality surveillance program for the meters and strips already on the market and being sold to patients

On July 1, Medicare established the Medicare National Mail-Order program, which drastically decreased the price of blood glucose testing supplies for people on Medicare, but requires people to get their supplies, including blood glucose trips, lancets, lancet devices, batteries and control solution, from a selection of 18 designated suppliers.

Novo Nordisk just announced that the FDA has cleared its NovoPen Echo insulin injection device, the only one available in the U.S. that’s able to deliver half-unit doses of insulin.

Google Ventures has just invested more than $10 million along with InCube Labs and VentureHealth in a series B round for Rani Therapeutics, a San Jose, California-based early stage start-up developing novel approaches for oral delivery of typically injected drugs like insulin and TNF alpha-inhibitors.

The idea of an all-in-one glucose meter that eliminates the need to carry around a bunch of separate D-supplies is so appealing! But in many respects it’s like the mirage of water on the desert horizon that we can never reach.

I’ve just started on the Dexcom G4 continuous glucose monitor myself, and a few weeks in I am absolutely loving the accuracy and sense of security it’s giving me at all hours of the day. It’s already provided early notice of a few low blood sugars, especially during the overnight hours that are the biggest […]

Why do some meters need to be “coded” and others do not? Is there a valid reason that strips come in boxes of 50 and 100?

Participants were between the ages of 2-19 years and had a history of diabetes ranging from 6 months to 15 ½ years. Both treatment groups started with the same HbA1c levels. During follow-up treatment, those on the insulin pump displayed an improved HbA1c level.

he test strips were taken from at least seven different vials of one manufacturing lot. Over at least ten days, the patients tested their blood sugar with the meter and then a second sample was taken for analysis in a lab. It’s quite an interesting read and I have broken it down into accuracy of […]

Basically, some leaders in the diabetes community got together, created a logo and website, and started shouting from the social media rooftops about a letter-writing campaign calling on authorities to crack down on the accuracy of glucose test strips. And guess what? The FDA responded.

What if (finally?) you could wear an insulin pump and continuous glucose monitor (CGM), and the two connected to your body in only one place, with no need for two separate infusion sites?

Why do you get such different blood sugar readings even though I eat the same thing for breakfast every day? Joslin Diabetes Blog has the answer.